bromfenac (ophthalmic) (cont.)
IN THIS ARTICLE
What should I discuss with my healthcare provider before using bromfenac ophthalmic (Xibrom)?
You should not use this medication if you have ever had an allergic reaction to bromfenac.
Before using bromfenac ophthalmic, tell your doctor if you are allergic to any drugs, or if you have:
If you have any of these conditions, you may need a dose adjustment or special tests to safely use bromfenac ophthalmic.
FDA pregnancy category C: This medication may be harmful to an unborn baby. Do not use bromfenac without telling your doctor if you are pregnant. Tell your doctor if you become pregnant during treatment.
It is not known if bromfenac ophthalmic passes into breast milk or if it could harm a nursing baby. Do not use this medication without telling your doctor if you are breast-feeding a baby.
How should I use bromfenac ophthalmic (Xibrom)?
Use bromfenac ophthalmic exactly as it was prescribed for you. Do not use it in larger doses or for longer than recommended by your doctor. Follow the directions on your prescription label.
Wash your hands before using the eye drops.
If you wear contact lenses, remove them before applying bromfenac ophthalmic. Ask your doctor if contact lenses can be reinserted after putting in the eye drops. Bromfenac ophthalmic may contain a preservative (benzalkonium chloride) that can cause discoloration of contact lenses.
To apply the eye drops:
Bromfenac ophthalmic is usually used two times a day for 14 days. Follow your doctor's directions.
Do not touch the dropper to any surface, including the eyes or hands. If the dropper becomes contaminated, it could cause an infection in your eye.
Store the drops at room temperature away from heat and moisture. Keep the bottle tightly closed when not in use.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Need help identifying pills and medications?
Get breaking medical news.